Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis

Journal of Cutaneous Medicine and Surgery
Kathryn L Anderson, Steven R Feldman

Abstract

Psoriasis treatment involves multiple treatment arms. Treatment choice depends on many factors and may change, due to the chronicity of psoriasis. The purpose of our study is to explore reasons for treatment changes in patients with moderate to severe psoriasis. Ten charts of patients with moderate to severe psoriasis were reviewed. The medication changes and reasons for change were extracted. A "treatment change" was defined as switching between medication classes, adding or removing a medication class, or switching medications within the oral or biologic medication class. Seventy-seven treatment changes were identified. On average, 1 treatment change occurred per year of follow-up. The most common reason for treatment change was inadequate disease control. Inadequate disease control with current therapy is the most common reason a physician changes treatment for moderate to severe psoriasis. More efficacious treatments or ways to improve efficacy may help improve the long-term outcomes of psoriasis.

References

Oct 31, 1997·Journal of the American Academy of Dermatology·S R FeldmanA R Clark
Feb 10, 2006·The Journal of Dermatological Treatment·Daniel J PearceSteven R Feldman
Jan 3, 2009·Journal of the American Academy of Dermatology·Joseph F FowlerGeorge Kosicki
Sep 22, 2010·The British Journal of Dermatology·Anthony D Ormerod
Oct 18, 2011·Acta Dermato-venereologica·Eva DueClaus Zachariae
Mar 7, 2012·North American Journal of Medical Sciences·Beharu Woldemedhin, Nasir Tajure Wabe
Jun 7, 2012·The Journal of Dermatological Treatment·Benjamin ChastekShravanthi R Gandra
Aug 1, 2012·Journal of the American Academy of Dermatology·Howa YeungJoel M Gelfand
Sep 28, 2012·The Journal of Investigative Dermatology·Rosa ParisiUNKNOWN Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team
Jun 26, 2013·Current Problems in Dermatology·Peter L MatteiAlexa B Kimball
Sep 3, 2013·Parkinsonism & Related Disorders·Michele TinazziUNKNOWN REASON Study Group
Dec 21, 2013·Journal of the American Academy of Dermatology·Stefano PiasericoUNKNOWN Psocare Study Group
Apr 2, 2014·BMC Pharmacology & Toxicology·Vanessa ChristePedro Marques-Vidal
May 13, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·A SvedbomM Ståhle

❮ Previous
Next ❯

Citations

Oct 21, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·M A RadtkeM Augustin
Aug 10, 2017·Journal of Cutaneous Medicine and Surgery·Jaclyn A SmithSteven R Feldman
Feb 17, 2018·The Journal of Dermatological Treatment·Erica B LeeJashin J Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

New Directions for Mental Health Services
R Bloom
Archivos de neurobiologiá
L Valenciano Gaya
Australian Dental Journal
W Thomas
© 2021 Meta ULC. All rights reserved